ロード中...
5PSQ-004 Adequacy and effectiveness of liraglutide in patients with type-2 diabetes mellitus
BACKGROUND: Liraglutide is a human glucagon-like peptide-1 analogue (GLP-1) indicated in the treatment of adults with type-2 diabetes mellitus to achieve glycaemic control, combined with oral antidiabetic agents, increases insulin secretion and decreases glucagon secretion, in a glucose-dependent ma...
保存先:
| 出版年: | Eur J Hosp Pharm |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Group
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535523/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.358 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|